Skip to content
Biodatica
Start free

Timser SAPI de CV

San Mateo Atenco, State of Mexico

OncologyGrant-only
Compare Sign in to watch

What changed

Study registered, no phase assigned: Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

4mo agoTrial registeredMar 18, 2026Source filing (opens the source filing in a new tab)

Momentum

72no change

Momentum 72 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

10,139 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Feb 27, 2026

    Atypical Squamous Cell of Undetermined Significance, ASC-US, Atypical Glandular Cells of Uncertain Significance, AGUS, Cervical Intraepithelial Neoplasia (CIN), CIN 1, CIN 2, CIN 3, Cervical Cancer · WITHDRAWN · sponsor: Timser SAPI de CV · Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

    ClinicalTrials.gov · NCT07211204 (opens the source filing in a new tab)

  2. Trial

    NA registered

    Feb 3, 2026

    I) Atypical Squamous Cells of Undetermined Significance (ASC-US), II) Atypical Glandular Cells of Uncertain Significance (AGUS), III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3, IV) Low-grade Squamous Intraepithelial Lesion (LSIL), V) High-grade Squamous Intraepithelial Lesion (HSIL), VI) Cervical Cancer · RECRUITING · sponsor: Timser SAPI de CV · Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

    ClinicalTrials.gov · NCT07480902 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources